新的ADHD药物规则旨在增强安全,但面临服务不足地区的资金问题。 New ADHD drug rules aim to boost safety but face funding concerns for underserved areas.

美国卫生与公众服务部宣布了用于开用ADDHD药物的更新规则,目的是改善病人安全和减少滥用,但立法者和保健倡导者对缺乏新的联邦资金支持实施表示关切,特别是在服务不足的社区。 The U.S. Department of Health and Human Services announced updated rules for prescribing ADHD medications, aiming to improve patient safety and reduce misuse, but lawmakers and health advocates are raising concerns about the absence of new federal funding to support implementation, particularly in underserved communities.